Autolus Therapeutics (AUTL) Research & Development (2017 - 2025)
Historic Research & Development for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $27.9 million.
- Autolus Therapeutics' Research & Development fell 3082.86% to $27.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.9 million, marking a year-over-year decrease of 2222.75%. This contributed to the annual value of $138.4 million for FY2024, which is 609.67% up from last year.
- As of Q3 2025, Autolus Therapeutics' Research & Development stood at $27.9 million, which was down 3082.86% from $27.4 million recorded in Q2 2025.
- Autolus Therapeutics' 5-year Research & Development high stood at $206.0 million for Q4 2021, and its period low was -$32.3 billion during Q3 2021.
- For the 5-year period, Autolus Therapeutics' Research & Development averaged around -$1.7 billion, with its median value being $30.8 million (2022).
- Within the past 5 years, the most significant YoY rise in Autolus Therapeutics' Research & Development was 43189.68% (2021), while the steepest drop was 9636471.9% (2021).
- Over the past 5 years, Autolus Therapeutics' Research & Development (Quarter) stood at $206.0 million in 2021, then crashed by 96.34% to $7.5 million in 2022, then soared by 397.39% to $37.5 million in 2023, then decreased by 17.88% to $30.8 million in 2024, then dropped by 9.53% to $27.9 million in 2025.
- Its Research & Development stands at $27.9 million for Q3 2025, versus $27.4 million for Q2 2025 and $26.7 million for Q1 2025.